Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/1/25 19:17 | 10/1/25 | XENE | Health | Drug | Pharmaceutical Preparations | Mortimer Ian | A1 | DO | P,CEO,IN | 2 | S.dm | -3,218 | 40.23 | 0 | -80 | 46 | D | |||||||||||||||
6/6/25 17:58 | 6/5/25 | XENE | Health | Drug | Pharmaceutical Preparations | Gannon Steven | A1 | D | 1 | S.d | 0 | 30.33 | 0 | 0 | 0 | 7 | D | |||||||||||||||
12/19/24 18:57 | 12/18/24 | XENE | Health | Drug | Pharmaceutical Preparations | Aulin Sherry | A1 | O | CFO | 1 | S.d | -771 | 41.21 | 0 | -19 | -100 | 0 | D | ||||||||||||||
11/22/24 19:48 | 11/22/24 | XENE | Health | Drug | Pharmaceutical Preparations | Patou Gary | A1 | D | 1 | S.d | -201 | 41.09 | 0 | -5 | 28 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |